Liposarcoma: Molecular Genetics and Therapeutics

Sarcoma · 2010 · Classic · cited 212 times

Rachel Conyers, Sophie Young, David M. Thomas

Sarcoma Genomics & Genetics, Peter MacCallum Cancer Centre, 12 St Andrews Place, Australia

Orthopaedic Oncology

SUMMARY — THE REDUCTIONLiposarcoma subtypes show distinct molecular abnormalities; understanding pathogenesis enables targeted therapeutic interventions.
Abstract, as published

Sarcomas are a group of heterogeneous tumours with varying genetic basis. Cytogenetic abnormalities range from distinct genomic rearrangements such as pathognomonic translocation events and common chromosomal amplification or loss, to more complex rearrangements involving multiple chromosomes. The different subtypes of liposarcoma are spread across this spectrum and constitute an interesting tumour type for molecular review. This paper will outline molecular pathogenesis of the three main subtypes of liposarcoma: well-differentiated/dedifferentiated, myxoid/round cell, and pleomorphic liposarcoma. Both the molecular basis and future avenues for therapeutic intervention will be discussed.

Featured in the 2026-06-29 issue.

← State-of-the-art of minimally invasive treatments of bone met…The role of molecular pathology in soft tissue tumor diagnosi… →

The Reduction is a free email digest of newly published orthopaedic literature — a handful of new papers in the subspecialties you choose, each summarized like this one. Subscribe free or browse the archive.